Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MiQ Partners is a private U.S. industrial automation and contract manufacturing company serving life sciences, medical device, and other industrial end markets. The company was formed after Resilience Capital Partners acquired and integrated TSS Technologies and R&3D Automation, and it later expanded its California footprint through the acquisition of CKC Engineering. MiQ designs and builds custom automation systems and provides systems integration, robotic assembly, testing, inspection, machining, build-to-print, and turnkey electro-mechanical contract manufacturing services. Within healthcare and life sciences, the company supports manufacturing applications such as drug delivery systems, diagnostic test kits, sample collection, aseptic syringe filling, and medicinal-product packaging. MiQ appears to be a supplier and manufacturing partner rather than a therapeutics developer, so it does not have a conventional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MiQ Partners.